NCT01523093View on ClinicalTrials.gov

Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

October 31, 2006

Conditions
Healthy
Interventions
DRUG

Ondansetron

Orally Disintegrating Tablets 8mg

Trial Locations (1)

Unknown

Clinical Pharmacology Unit, Majeedia Hospital (2nd Floor), New Delhi

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT01523093 - Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions | Biotech Hunter | Biotech Hunter